注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
PDS Biotechnology Corp是一家临床阶段的免疫治疗公司。该公司致力于开发一系列分子靶向免疫疗法。该公司拥有T细胞激活平台,旨在训练免疫系统攻击和摧毁疾病。该公司的Versamune用于治疗肿瘤学,Infectimune用于治疗传染病。Infectimune还旨在促进诱导疾病特异性中和抗体。该公司的免疫肿瘤学产品候选者具有潜在能力,可用作组合候选产品的组成部分,以提供针对一系列晚期和/或难治性癌症的治疗。该公司开发有针对性的候选产品来治疗多种癌症,包括人乳头瘤病毒(HPV)相关癌症、黑色素瘤、结肠直肠癌、肺癌、乳腺癌和前列腺癌。该公司的传染病候选产品作为预防COVID-19和普遍流感的疫苗具有潜在的价值。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Neil Gross | - | - | Member of Scientific Advisory Board |
Frank K. Bedu-Addo | 59 | 2019 | President, CEO & Director |
Jerold G. Woodward | - | - | Member of Scientific Advisory Board |
Ilian Petkov Iliev | 49 | 2020 | Director |
Otis W. Brawley | 64 | 2020 | Independent Director |
Mark W. Frohlich | 62 | 2021 | Member of Scientific Advisory Board |
Richard Sykes | 79 | 2019 | Independent Director |
Olivera J. Finn | - | 2021 | Member of Scientific Advisory Board |
Gregory G. Freitag | 62 | 2019 | Independent Director |
Leaf Huang | - | - | Member of Scientific Advisory Board |
Lisa Rohan | - | - | Chair of the Scientific Advisory Board |
Samir N. Khleif | 60 | - | Member of Scientific Advisory Board |
Mark H. Einstein | - | - | Member of Scientific Advisory Board |
Darron R. Brown | - | - | Member of Scientific Advisory Board |
Kamil Ali-Jackson | 65 | 2020 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核